Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 36101-36150 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06275113
BRING-UP Prevention
N/ARecruiting
6,000 participants
Started: Sep 15, 2023 · Completed: Jun 30, 2026
3 conditions1 sponsor196 locations
NCT05635123
A Cohort Study of Uterine Malignancies
N/ARecruiting
6,200 participants
Started: Sep 15, 2023 · Completed: Dec 1, 2030
2 conditions1 sponsor1 location
NCT05880940
Comparing Different Rehabilitation Exercise Strategies for Improving Arm Recovery After Stroke
NARecruiting
60 participants
Started: Sep 15, 2023 · Completed: Aug 31, 2025
1 condition5 sponsors3 locations
NCT06016465
Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
EARLY_PHASE1Recruiting
84 participants
Started: Sep 15, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT05087680
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
NARecruiting
66 participants
Started: Sep 14, 2023 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT06257628
MACE CDS Software Master Enrollment Protocol
N/ARecruiting
5,515 participants
Started: Sep 14, 2023 · Completed: Apr 11, 2025
1 condition1 sponsor3 locations
NCT06569524
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
PHASE2Recruiting
120 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor53 locations
NCT06324318
Parenting in 2 Worlds Multisite Trial
PHASE2Recruiting
1,440 participants
Started: Sep 14, 2023 · Completed: Jun 1, 2028
4 conditions6 sponsors4 locations
NCT06158464
The Effectiveness of a Functional Capacity Evaluation Among Persons on Sick Leave or Work Disability
NARecruiting
200 participants
Started: Sep 14, 2023 · Completed: Aug 31, 2024
3 conditions3 sponsors8 locations
NCT05691504
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
PHASE1Recruiting
42 participants
Started: Sep 14, 2023 · Completed: Feb 1, 2027
11 conditions1 sponsor6 locations
NCT06016062
A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
PHASE1/PHASE2Recruiting
221 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor31 locations
NCT05569772
Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes
PHASE3Recruiting
252 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2028
1 condition14 sponsors13 locations
NCT06066645
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
PHASE3Recruiting
150 participants
Started: Sep 14, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05276219
Optimized Treatment of Pulmonary Edema or Congestion
PHASE4Recruiting
1,104 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2026
3 conditions4 sponsors4 locations
NCT05699226
Amplitude Titration to Improve ECT Clinical Outcomes
NARecruiting
50 participants
Started: Sep 14, 2023 · Completed: Jan 30, 2026
3 conditions2 sponsors1 location
NCT05872295
IKS014 in Advanced Solid Tumors That Express HER2
PHASE1Recruiting
165 participants
Started: Sep 14, 2023 · Completed: Sep 30, 2027
3 conditions1 sponsor12 locations
NCT06086405
ECMO Braile Biomédica® in COVID-19 Patients
N/ARecruiting
30 participants
Started: Sep 14, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05949047
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
NARecruiting
270 participants
Started: Sep 14, 2023 · Completed: May 31, 2027
6 conditions2 sponsors1 location
NCT06401837
Acupressure Therapy on Post-stroke Fatigue, Depression, and Sleep Disturbances in Ischemic Stroke Patients
NARecruiting
78 participants
Started: Sep 14, 2023 · Completed: Jul 31, 2025
6 conditions2 sponsors2 locations
NCT05641116
Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.
NARecruiting
62 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor2 locations
NCT06193538
The Safety and Effectiveness of NV-A01 in Glioma Patients
PHASE1Recruiting
15 participants
Started: Sep 14, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05917405
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
PHASE2Recruiting
302 participants
Started: Sep 14, 2023 · Completed: Sep 14, 2028
1 condition1 sponsor23 locations
NCT06032338
Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering
NARecruiting
64,000 participants
Started: Sep 14, 2023 · Completed: Nov 14, 2026
1 condition3 sponsors1 location
NCT06334445
CARDIOCARE Prospective Clinical Study
N/ARecruiting
736 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06182072
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1Recruiting
46 participants
Started: Sep 14, 2023 · Completed: Jun 30, 2028
1 condition3 sponsors1 location
NCT06034275
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
PHASE1Recruiting
36 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor5 locations
NCT06075199
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
N/ARecruiting
1,000 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2033
1 condition1 sponsor1 location
NCT06032845
Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)
PHASE2Recruiting
25 participants
Started: Sep 13, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06266286
EXOPULSE Mollii Suit & Cerebral Palsy
NARecruiting
32 participants
Started: Sep 13, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor4 locations
NCT06045013
Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone in Carpal Tunnel Syndrome
PHASE3Recruiting
70 participants
Started: Sep 13, 2023 · Completed: Aug 30, 2026
1 condition3 sponsors1 location
NCT05999214
99mTc-H7ND SPECT/CT Imaging in NSCLC
NARecruiting
150 participants
Started: Sep 13, 2023 · Completed: Aug 10, 2026
1 condition1 sponsor1 location
NCT06476912
Balance Exercise and Vagus Nerve Stimulation on Weight-shifting Control and Ambulation in Parkinson Disease and Anxiety
NARecruiting
94 participants
Started: Sep 13, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06202209
The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
N/ARecruiting
100 participants
Started: Sep 13, 2023 · Completed: Oct 30, 2024
1 condition3 sponsors1 location
NCT05520346
Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
NARecruiting
54 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06590025
Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression
PHASE3Recruiting
296 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06036706
Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
NARecruiting
108 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2039
2 conditions2 sponsors3 locations
NCT05487807
Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
PHASE1Recruiting
800 participants
Started: Sep 13, 2023 · Completed: Aug 31, 2026
2 conditions2 sponsors2 locations
NCT06806787
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
N/ARecruiting
30 participants
Started: Sep 13, 2023 · Completed: Mar 14, 2026
1 condition1 sponsor1 location
NCT05869955
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
PHASE1Recruiting
270 participants
Started: Sep 13, 2023 · Completed: Aug 29, 2028
4 conditions2 sponsors54 locations
NCT05832086
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
PHASE2Recruiting
138 participants
Started: Sep 13, 2023 · Completed: Mar 30, 2029
1 condition2 sponsors3 locations
NCT05954442
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
PHASE3Recruiting
203 participants
Started: Sep 13, 2023 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05991453
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
NARecruiting
13,000 participants
Started: Sep 13, 2023 · Completed: Jul 31, 2028
8 conditions3 sponsors20 locations
NCT05878717
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
PHASE2/PHASE3Recruiting
300 participants
Started: Sep 13, 2023 · Completed: Jul 12, 2027
2 conditions1 sponsor130 locations
NCT06045260
"Receptor Radionuclide Therapy With 177Lu-DOTATOC"
PHASE2Recruiting
100 participants
Started: Sep 13, 2023 · Completed: Jan 31, 2027
3 conditions1 sponsor2 locations
NCT06029049
Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine
PHASE4Recruiting
152 participants
Started: Sep 13, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05650658
Left vs Left Randomized Clinical Trial
NARecruiting
2,136 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2029
7 conditions6 sponsors71 locations
NCT06104085
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
NARecruiting
30 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06259669
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
N/ARecruiting
958 participants
Started: Sep 13, 2023 · Completed: Aug 1, 2033
2 conditions1 sponsor1 location
NCT05377905
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
PHASE1/PHASE2Recruiting
48 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06121245
The PRO-SOma COla (PROSOCO) Study
NARecruiting
11 participants
Started: Sep 13, 2023 · Completed: Feb 29, 2024
1 condition2 sponsors2 locations